Published in Springerplus on March 21, 2013
Recent progress regarding the bioactivities, biosynthesis and synthesis of naturally occurring resorcinolic macrolides. Acta Pharmacol Sin (2014) 0.80
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
The cholinergic hypothesis of geriatric memory dysfunction. Science (1982) 6.84
Free radical scavenging activities of mushroom polysaccharide extracts. Life Sci (1997) 2.68
Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA (1994) 2.18
Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today (2000) 1.74
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure (1999) 1.74
Antioxidative activity of natural products from plants. Life Sci (2000) 1.56
Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry (2002) 1.49
Acetylcholinesterase inhibitors in Alzheimer's disease. Br J Clin Pharmacol (1999) 1.40
Three metabolites from the mangrove endophytic fungus Sporothrix sp. (#4335) from the South China Sea. J Org Chem (2009) 1.37
Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem (2001) 1.37
Extracellular synthesis of silver nanoparticles using culture supernatant of Pseudomonas aeruginosa. Colloids Surf B Biointerfaces (2011) 1.29
Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr A (2001) 1.26
Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol (2005) 1.21
Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution. FEBS Lett (1999) 1.11
Characterization of the radical scavenging activity of lignins--natural antioxidants. Bioresour Technol (2004) 1.06
Tacrine. Lancet (1995) 1.04
The epidemic of Alzheimer's disease. How can we manage the costs? Pharmacoeconomics (2000) 0.97
Antifungal activity of cinnamaldehyde and eugenol congeners against wood-rot fungi. Bioresour Technol (2007) 0.92
Arisugacins A and B, novel and selective acetylcholinesterase inhibitors from Penicillium sp. FO-4259. I. Screening, taxonomy, fermentation, isolation and biological activity. J Antibiot (Tokyo) (1996) 0.89
Unconventional natural sources for future drug discovery. Drug Discov Today (2004) 0.88
A new anthraquinone and cytotoxic curvularins of a Penicillium sp. from the rhizosphere of Fallugia paradoxa of the Sonoran desert. J Antibiot (Tokyo) (2004) 0.88
Physicochemical characterization and antioxidant activity of melanin from a novel strain of Aspergillus bridgeri ICTF-201. Lett Appl Microbiol (2011) 0.87
Antimicrobial compounds of fungi vectored by Clusia spp. (Clusiaceae) pollinating bees. Z Naturforsch C (2003) 0.85
The rationale for E2020 as a potent acetylcholinesterase inhibitor. Bioorg Med Chem (1996) 0.85
From the Food and Drug Administration. JAMA (1997) 0.83
Bioactive metabolites from the fungus Nectria galligena, the main apple canker agent in Chile. J Agric Food Chem (2005) 0.83
Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking. Eur J Med Chem (2007) 0.83
Isolation and difference in anti-Staphylococcus aureus bioactivity of curvularin derivates from fungus Eupenicillium sp. Appl Biochem Biotechnol (2009) 0.83
Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors. J Mol Graph Model (2007) 0.83
Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads. J Chem Inf Model (2010) 0.82
Quinolactacins A1 and A2, new acetylcholinesterase inhibitors from Penicillium citrinum. J Antibiot (Tokyo) (2001) 0.82
Betagamma-dehydrocurvularin and related compounds as nematicides of Pratylenchus penetrans from the fungus Aspergillus sp. Biosci Biotechnol Biochem (2003) 0.81
Terreulactones A, B, C, and D: novel acetylcholinesterase inhibitors produced by Aspergillus terreus. II. Physico-chemical properties and structure determination. J Antibiot (Tokyo) (2003) 0.79
QSAR study of anticoccidial activity for diverse chemical compounds: prediction and experimental assay of trans-2-(2-nitrovinyl)furan. Bioorg Med Chem (2006) 0.79
Design of 1-arylsulfamido-2-alkylpiperazine derivatives as secreted PLA2 inhibitors. J Mol Model (2010) 0.78
Isolation of a, beta-dehydrocurvularin from Aspergillus aureofulgens. Planta Med (1977) 0.77
Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound. Bioorg Med Chem Lett (1999) 0.77
Current status and new developments with galantamine in the treatment of Alzheimer's disease. Expert Opin Pharmacother (2001) 0.76
Cation-π interaction: its role and relevance in chemistry, biology, and material science. Chem Rev (2012) 1.49
Phytochemical investigation of labdane diterpenes from the rhizomes of Hedychium spicatum and their cytotoxic activity. Bioorg Med Chem Lett (2009) 1.46
Virtual screening in drug discovery -- a computational perspective. Curr Protein Pept Sci (2007) 1.32
Choline kinase: an important target for cancer. Curr Med Chem (2006) 1.16
Potent in vitro antifungal activities of naturally occurring acetylenic acids. Antimicrob Agents Chemother (2008) 1.15
Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison. Indian J Ophthalmol (2006) 1.03
The significance of the alkene size and the nature of the metal ion in metal-alkene complexes: a theoretical study. Dalton Trans (2012) 1.02
Is microsporidial keratitis an emerging cause of stromal keratitis? A case series study. BMC Ophthalmol (2005) 1.01
Homology modeling of membrane proteins: a critical assessment. Comput Biol Chem (2006) 1.01
Exploring the size dependence of cyclic and acyclic pi-systems on cation-pi binding. Phys Chem Chem Phys (2007) 0.98
In vitro efficacy of cefazolin and povidone-iodine 5% in eradicating microbial organisms adhered to broad scleral buckles. Clin Experiment Ophthalmol (2006) 0.98
Comprehensive study on the solvation of mono- and divalent metal cations: Li+, Na+, K+, Be2+, Mg2+ and Ca2+. J Phys Chem A (2008) 0.98
Synthesis, structure analysis, and antibacterial activity of some novel 10-substituted 2-(4-piperidyl/phenyl)-5,5-dioxo[1,2,4]triazolo[1,5-b][1,2,4]benzothiadiazine derivatives. Bioorg Med Chem Lett (2007) 0.97
Where to bind in buckybowls? The dilemma of a metal ion. Phys Chem Chem Phys (2012) 0.97
Tankyrase inhibitors as therapeutic targets for cancer. Curr Top Med Chem (2014) 0.96
On the cooperativity of cation-pi and hydrogen bonding interactions. J Phys Chem B (2008) 0.96
Cation [M = H+, Li+, Na+, K+, Ca2+, Mg2+, NH4+, and NMe4+] interactions with the aromatic motifs of naturally occurring amino acids: a theoretical study. J Phys Chem A (2005) 0.94
What factors influence the rate constant of substrate epoxidation by compound I of cytochrome P450 and analogous iron(IV)-oxo oxidants? J Am Chem Soc (2010) 0.94
Aromatic-Aromatic Interactions Database, A(2)ID: an analysis of aromatic π-networks in proteins. Int J Biol Macromol (2011) 0.92
Microsporidial keratitis: need for increased awareness. Surv Ophthalmol (2010) 0.92
Non-invasive ventilation in chronic obstructive pulmonary disease. BMJ (2003) 0.92
A new sesquiterpene lactone from the roots of Saussurea lappa: structure-anticancer activity study. Bioorg Med Chem Lett (2008) 0.92
Plant HDAC inhibitor chrysin arrest cell growth and induce p21WAF1 by altering chromatin of STAT response element in A375 cells. BMC Cancer (2012) 0.91
Mechanism of S-oxygenation by a cysteine dioxygenase model complex. J Phys Chem A (2011) 0.90
Comparison of computational methods to model DNA minor groove binders. J Chem Inf Model (2011) 0.89
Subtype selectivity in phosphodiesterase 4 (PDE4): a bottleneck in rational drug design. Curr Pharm Des (2008) 0.87
Natural Product Based 6-Hydroxy-2,3,4,6-tetrahydropyrrolo[1,2-a]pyrimidinium Scaffold as A New Antifungal Template. ACS Med Chem Lett (2011) 0.86
Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril (2008) 0.86
Raised intraocular pressure and orbital inflammation: a rare IgE-mediated allergic reaction to sub-Tenon's hyaluronidase. J Cataract Refract Surg (2006) 0.86
Viability of clathrate hydrates as CO2 capturing agents: a theoretical study. J Phys Chem A (2011) 0.85
Methyl cation affinities of commonly used organocatalysts. J Am Chem Soc (2008) 0.85
Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes. Retina (2011) 0.85
Reduction of the multiple pregnancy rate in a preimplantation genetic diagnosis programme after introduction of single blastocyst transfer and cryopreservation of blastocysts biopsied on day 3. Hum Reprod (2009) 0.85
Protein ligand interaction database (PLID). Comput Biol Chem (2008) 0.85
Metabolic profiling and biological activities of bioactive compounds produced by Pseudomonas sp. strain ICTB-745 isolated from Ladakh, India. J Microbiol Biotechnol (2012) 0.85
Effect of the axial ligand on substrate sulfoxidation mediated by iron(IV)-oxo porphyrin cation radical oxidants. Chemistry (2011) 0.85
Cation-pi interactions of bare and coordinatively saturated metal ions: contrasting structural and energetic characteristics. J Phys Chem B (2007) 0.85
Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches. J Chem Inf Model (2012) 0.84
Two new cytotoxic labdane diterpenes from the rhizomes of Hedychium coronarium. Bioorg Med Chem Lett (2010) 0.83
Explicit solvent effect on cation-pi interactions: a first principle investigation. J Phys Chem B (2009) 0.83
Potential choline kinase inhibitors: a molecular modeling study of bis-quinolinium compounds. J Mol Graph Model (2008) 0.83
Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids. Bioorg Med Chem Lett (2014) 0.83
New bioactive macrocyclic diterpenoids from Jatropha multifida. Bioorg Med Chem Lett (2011) 0.83
Molecular modeling studies of pyridopurinone derivatives--potential phosphodiesterase 5 inhibitors. J Mol Graph Model (2007) 0.83
Optimization of nitrilase production from Alcaligenes faecalis MTCC 10757 (IICT-A3): effect of inducers on substrate specificity. Bioprocess Biosyst Eng (2010) 0.82
Soft tissue defects of the heel: a surgical reconstruction algorithm based on a retrospective cohort study. J Foot Ankle Surg (2008) 0.82
Axial ligand effect on the rate constant of aromatic hydroxylation by iron(IV)-oxo complexes mimicking cytochrome P450 enzymes. J Phys Chem B (2011) 0.82
Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads. J Chem Inf Model (2010) 0.82
Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo[2,1-c][1,4]benzodiazepines and their anticancer potential. Bioorg Med Chem (2009) 0.82
Eagle syndrome; radiological evaluation and management. J Pak Med Assoc (2014) 0.82
Formation of linear polymers with pendant vinyl groups via inclusion complex mediated polymerization of divinyl monomers. J Am Chem Soc (2006) 0.82
Cation-aromatic database. Proteins (2007) 0.82
Novel targets for antiinflammatory and antiarthritic agents. Curr Pharm Des (2006) 0.81
Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach. J Mol Graph Model (2012) 0.80
Aromatase inhibitors: a new paradigm in breast cancer treatment. Curr Med Chem Anticancer Agents (2004) 0.80
Generation of regiospecific carbanions under electrospray ionisation conditions and their selectivity in ion-molecule reactions with CO2. Rapid Commun Mass Spectrom (2006) 0.80
Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorg Med Chem Lett (2013) 0.80
Hydrogen bonding in water clusters and their ionized counterparts. J Phys Chem B (2010) 0.79
Green synthesis of Kocuran-functionalized silver glyconanoparticles for use as antibiofilm coatings on silicone urethral catheters. Nanotechnology (2014) 0.79
Estimating the stereoinductive potential of cinchona alkaloids with a prochiral probe approach. Org Lett (2008) 0.79
Oxidative properties of a nonheme Ni(II)(O2) complex: Reactivity patterns for C-H activation, aromatic hydroxylation and heteroatom oxidation. Chem Commun (Camb) (2011) 0.79
Ab initio investigation of benzene clusters: molecular tailoring approach. J Chem Phys (2010) 0.79
Density functional theory study on the effect of substitution and ring annelation to the rim of corannulene. J Org Chem (2004) 0.79
Recent advances in molecular modeling and medicinal chemistry aspects of phospho-glycoprotein. Curr Drug Metab (2006) 0.79
Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines--their potential as adenosine receptor ligands. Eur J Med Chem (2010) 0.79
Rapid access to novel 1,2,3-triazolo-heterocyclic scaffolds via tandem Knoevenagel condensation/azide-alkyne 1,3-dipolar cycloaddition reaction in one pot. ACS Comb Sci (2014) 0.79
FDA approved drugs complexed to their targets: evaluating pose prediction accuracy of docking protocols. J Mol Model (2012) 0.79
Isolation and identification of diadenosine 5',5'''-P1,P4-tetraphosphate binding proteins using magnetic bio-panning. Bioorg Med Chem Lett (2011) 0.78
Rational approaches towards lead optimization of kinase inhibitors: the issue of specificity. Curr Pharm Des (2013) 0.78
Stereoelectronic effect of curved aromatic structures: favoring the unexpected endo conformation of benzylic-substituted sumanene. Angew Chem Int Ed Engl (2013) 0.78
Cyclotriphosphazene ring as a platform for multiporphyrin assemblies. Chemistry (2009) 0.78
NMR structural studies on the covalent DNA binding of a pyrrolobenzodiazepine-naphthalimide conjugate. Org Biomol Chem (2010) 0.78
Spectroscopic and calorimetric studies on the DNA recognition of pyrrolo[2,1-c][1,4]benzodiazepine hybrids. Bioorg Med Chem (2008) 0.78
Impact of the chirality and curvature of carbon nanostructures on their interaction with aromatics and amino acids. Chemphyschem (2013) 0.78
Interaction of pyrrolobenzodiazepine (PBD) ligands with parallel intermolecular G-quadruplex complex using spectroscopy and ESI-MS. PLoS One (2012) 0.78
Modeling anti-HIV compounds: the role of analogue-based approaches. Curr Comput Aided Drug Des (2012) 0.78
From subtle to substantial: role of metal ions on pi-pi interactions. J Phys Chem B (2006) 0.78
Competitive Diels-Alder reactions: cyclopentadiene and phospholes with butadiene. J Phys Chem A (2005) 0.78
Steric factors override thermodynamic driving force in regioselectivity of proline hydroxylation by prolyl-4-hydroxylase enzymes. J Phys Chem A (2010) 0.78
Technology evaluation: mepolizumab, GlaxoSmithKline. Curr Opin Mol Ther (2003) 0.78
A theoretical study on interaction of cyclopentadienyl ligand with alkali and alkaline earth metals. J Phys Chem B (2010) 0.78
Canaliculitis With Isolation of Myroides Species. Ophthal Plast Reconstr Surg (2015) 0.77
Characterization of calcium and magnesium binding domains of human 5-lipoxygenase. Biochem Biophys Res Commun (2004) 0.77
The impact of spermatozoa preincubation time and spontaneous acrosome reaction in intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril (2008) 0.77
Profiling of esterified fatty acids as biomarkers in the blood of dengue fever patients using a microliter-scale extraction followed by gas chromatography and mass spectrometry. J Sep Sci (2014) 0.77
Virtual high throughput screening in new lead identification. Comb Chem High Throughput Screen (2011) 0.77
Synthesis, structural characterization and biological evaluation of novel [1,2,4]triazolo [1,5-b][1,2,4]benzothiadiazine-benzothiazole conjugates as potential anticancer agents. Chem Biol Drug Des (2007) 0.77
Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect. Biomaterials (2013) 0.77
Solution structure of a covalently bound pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole hybrid to a 10mer DNA duplex. Biochemistry (2009) 0.77
Efficient estimation of MMGBSA-based BEs for DNA and aromatic furan amidino derivatives. J Biomol Struct Dyn (2012) 0.77
Design, synthesis and cytotoxic studies on the simplified oxy analog of eleutherobin. Bioorg Med Chem Lett (2004) 0.77
Tumor necrosis factor-alpha in severe corticosteroid-refractory asthma. Expert Rev Respir Med (2007) 0.77
Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole-pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem (2010) 0.77
Conjugate acene fused buckybowls: evaluating their suitability for p-type, ambipolar and n-type air stable organic semiconductors. Phys Chem Chem Phys (2013) 0.77
The efficacy of conceptual DFT descriptors and docking scores on the QSAR models of HIV protease inhibitors. Med Chem (2012) 0.76
Analysis of HIV protease binding pockets based on 3D shape and electrostatic potential descriptors. Chem Biol Drug Des (2011) 0.76
Proton binding sites and conformational analysis of H+K(+)-ATPase. Biochem Biophys Res Commun (2005) 0.76
Propargyl/methyl furanosides as potential glycosyl donors. Chem Commun (Camb) (2011) 0.76
Synthesis and biological evaluation of mercapto triazolo-benzothiadiazine linked aminobenzothiazoles as potential anticancer agents. Chem Biol Drug Des (2009) 0.76